You just read:

CELTIC THERAPEUTICS AND BELLUS HEALTH INITIATE CONFIRMATORY PHASE III CLINICAL STUDY FOR KIACTA™, A DRUG CANDIDATE FOR THE TREATMENT OF AA AMYLOIDOSIS

News provided by

BELLUS HEALTH INC.

Dec 15, 2010, 08:45 EST